Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2023 | 04-2023 | 01-2023 | 12-2022 | 10-2022 | |
| Operating Expenses | 1,103 | 1,656 | 1,833 | 1,247 | 0 |
| Operating Income | -1,103 | -1,656 | -1,833 | -1,247 | N/A |
| Other Income | 521 | -411 | -63 | 0 | 0 |
| Pre-tax Income | -582 | -2,067 | -1,896 | -1,247 | 0 |
| Income Tax | -7 | 9 | 3 | N/A | N/A |
| Net Income Continuous | -575 | -2,076 | -1,900 | 0 | -1,435 |
| Net Income | $-575 | $-2,076 | $-1,900 | $-1,826 | $-1,435 |
| EPS Basic Total Ops | -97.20 | -664.80 | -992.00 | N/A | -2,820.86 |
| EPS Basic Continuous Ops | -97.37 | -664.44 | -992.02 | N/A | -2,827.71 |
| EPS Diluted Total Ops | -97.20 | -664.80 | -992.00 | N/A | -2,820.86 |
| EPS Diluted Continuous Ops | -97.37 | -664.44 | -992.02 | N/A | -2,827.71 |
| EBITDA(a) | $-1,094 | $-1,652 | $-1,829 | $-1,223 | $7 |